Z-N-Me-Asp(OtBu)-OH DCHA is a protected aspartate derivative with N-methylation and tert-butyl esterification. These modifications adjust steric profile, backbone rigidity, and coupling selectivity. Researchers use it to generate constrained peptidomimetics and examine methylation effects on structure. Its dual protection supports orthogonal synthesis.
CAT No: R2158
CAS No:200341-08-8
Synonyms/Alias:Z-N-Me-Asp(OtBu)-OH DCHA;42417-70-9;200341-08-8;Dicyclohexylamine (S)-2-(((benzyloxy)carbonyl)(methyl)amino)-4-(tert-butoxy)-4-oxobutanoate;N-cyclohexylcyclohexanamine;(2S)-2-[methyl(phenylmethoxycarbonyl)amino]-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid;MFCD00237355;SCHEMBL248887;VTIXCSIGDUSBDL-ZOWNYOTGSA-N;(2S)-2-{[(benzyloxy)carbonyl](methyl)amino}-4-(tert-butoxy)-4-oxobutanoic acid; N-cyclohexylcyclohexanamine;AS-82795;G78119;S-42417-70-9;Z-N-Methyl-L-aspartic acid beta-t-butyl ester dicyclohexylammonium salt;dicyclohexylamine (S)-2-((benzyloxycarbonyl)(methyl)amino)-4-tert-butoxy-4-oxobutanoate;Dicyclohexylamine(S)-2-(((benzyloxy)carbonyl)(methyl)amino)-4-(tert-butoxy)-4-oxobutanoate;L-Asparticacid,N-methyl-N-[(phenylmethoxy)carbonyl]-,4-(1,1-dimethylethyl)ester;(s)-2-((benzyloxycarbonyl)(methyl)amino)-4-tert-butoxy-4-oxobutanoic acid dicyclohexylammonium salt;
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.